Q1 revenue declined 19% YoY to Rs 8.2 bn (~14% below estimate) as export shipments were impacted due to setting up of revised protocols as stipulated in the import alert by the USFDA. As per the management, the protocols have now been established; expects normalcy from Q2. Divis guides for flat cc r..